Abstract:Methylene blue (MB) has a long story of use and has been employed for various diseases, however, most of its current rekindled research is related to its function in the mitochondria. MB is gaining interest as a possible treatment because mitochondrial dysfunction is an apparent unifying pathogenic characteristic of a variety of neurodegenerative conditions. Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by impairment of cognitive functions. This study aims to investigate whether MB treatment improves impaired cognitive functions and reduces hippocampal amyloid-β levels and oxidative stress in a D-galactose-induced AD mouse model. Twenty-four wild-type Balb/c mice were randomly divided into four groups (control, D-galactose-induced AD, MB-treated AD, and only MB-treated mice). Mice in the corresponding groups were injected with D-galactose (50 mg/kg, s.c.) for 60 days. In the MB treatment groups, the mice were treated with MB (2 mg/kg, orally) for the last 14 days of treatments. The Morris water maze test was used to assess spatial learning and memory functions. Amyloid β-42, malondialdehyde, superoxide dismutase, and nitric oxide levels in the hippocampi of mice were measured using ELISA and spectrophotometry. MB treatment improved impaired learning and memory functions induced by D-galactose administration and decreased amyloid β-42 concentration in the hippocampi of mice. Malondialdehyde level was found to decrease in MB-treated mice compared to D-galactose-induced AD mice in the hippocampus and plasma. The hippocampus of MB-treated mice displayed increased superoxide dismutase activity while decreased nitric oxide concentration compared to the ones of D-galactose-induced AD mice. MB has been shown to improve learning and memory impairments, as well as reduce Aβ-42 concentration and oxidative stress in the hippocampus of D-galactose-induced AD mice. The findings of this study demonstrate that MB may offer potential benefits as a repurposed agent for AD.

The Potentials of Methylene Blue as an Anti-Aging Drug

Anti-Aging Potentials of Methylene Blue for Human Skin Longevity

Molecular Mechanisms of the Neuroprotective Effect of Methylene Blue

Targeting Mitochondrial Quality Control in Muscle Aging: Natural Dietary Products As Potential Interventions

Targeting mitochondrial dysfunction using methylene blue or mitoquinone to improve skeletal aging

Methylene blue and its potential in the treatment of traumatic brain injury, brain ischemia, and Alzheimer's disease

Mitochondria: A Potential Rejuvenation Tool against Aging

Ultraviolet radiation protection potentials of Methylene Blue for human skin and coral reef health

Methylene Blue Attenuates Impaired Cognitive Functions and Reduces Hippocampal Aβ Levels and Oxidative Stress in D-Galactose-Induced Alzheimer's Disease Mouse Model

The Effects of Methylene Blue on Autophagy and Apoptosis in Mri-Defined Normal Tissue, Ischemic Penumbra and Ischemic Core

Methylene blue alleviates nuclear and mitochondrial abnormalities in progeria

The Potential of Mitochondrial Therapeutics in the Treatment of Oxidative Stress and Inflammation in Aging

The Effects of Methylene Blue on Autophagy and Apoptosis in MRI‐defined Normal Tissue, Ischemic Penumbra and Ischemic Core

Biochemical Targets and Molecular Mechanism of Matrine against Aging

Methionine restriction- Association with redox homeostasis and implications on aging and diseases

Potential Active Marine Peptides as Anti-Aging Drugs or Drug Candidates

Methods for the discovery of new anti-aging products – targeted approaches

Engineered Mitochondrial Transplantation as An Anti-Aging Therapy

Marine Bioactive Peptides: Anti-Photoaging Mechanisms and Potential Skin Protective Effects

Enhancing healthy aging with small molecules: A mitochondrial perspective

Molecular mechanisms of aging and anti-aging strategies